Gut Microbial Taxonomic Profiles Differ With, Without Preclinical Alzheimer Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, June 16, 2023 -- Gut microbial taxonomic profiles are distinct for individuals with and without preclinical Alzheimer disease (AD), according to a study published in the June 14 issue of Science Translational Medicine.
Aura L. Ferreiro, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues conducted a cross-sectional study to compare the taxonomic composition and gut microbial function in a cohort of 164 cognitively normal individuals, 49 of whom showed biomarker evidence of early preclinical AD. Participants were recruited from existing longitudinal cohort studies.
The researchers observed an association for the change in gut microbiome composition with altered β-amyloid and tau pathological biomarkers in the brain, but not with biomarkers of neurodegeneration. Specific gut bacterial taxa associated with preclinical AD were identified. Gut species most linked to preclinical AD status included Dorea formicigenerans, Oscillibacter sp. 57_20, Faecalibacterium prausnitzii, Coprococcus catus, and Anaerostipes hadrus. When tested on a subset of the cohort (65 of 164 participants), inclusion of these microbiome features improved the accuracy, sensitivity, and specificity of machine learning classifiers for predicting AD status.
"Microbiome markers in stool might complement early screening measures for preclinical AD and generate encouraging hypotheses about potential roles of the gut in AD progression," the authors write.
Several authors disclosed ties to the biotechnology and pharmaceutical industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Self-, Partner-Reported Cognitive Decline Linked to Tau
THURSDAY, May 30, 2024 -- Individuals who self-report and whose partners report cognitive decline have greater tau, which is driven by elevated beta-amyloid (Aβ), according...
Socioeconomic Status Transitions Tied to Dementia Risk
THURSDAY, May 23, 2024 -- Upward and downward socioeconomic status (SES) transitions are associated with the risk for dementia and the length of dementia-free periods during the...
Half of Native Americans Older Than 70 Years May Have Cognitive Impairment
FRIDAY, May 17, 2024 -- More than half of Native Americans aged 70 years and older have cognitive impairment, according to a study published online May 15 in Alzheimer's...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.